PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 209 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -50.0% | 14 | -65.0% | 0.00% | – |
| Q3 2020 | $2,000 | -66.7% | 40 | -76.5% | 0.00% | – |
| Q1 2020 | $6,000 | -25.0% | 170 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +14.3% | 170 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | 0.0% | 170 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | +16.7% | 170 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | -14.3% | 170 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | -46.2% | 170 | -37.0% | 0.00% | 0.0% |
| Q3 2018 | $13,000 | +18.2% | 270 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | +37.5% | 270 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | 0.0% | 270 | +58.8% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | +33.3% | 170 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | -25.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | 0.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | -93.5% | 170 | -94.3% | 0.00% | -97.3% |
| Q3 2015 | $123,000 | -41.4% | 3,000 | 0.0% | 0.04% | -40.3% |
| Q2 2015 | $210,000 | -18.6% | 3,000 | 0.0% | 0.06% | -12.7% |
| Q1 2015 | $258,000 | -11.3% | 3,000 | 0.0% | 0.07% | -33.0% |
| Q3 2014 | $291,000 | – | 3,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |